Toxic effects and biodistribution of ultrasmall gold nanoparticles.

Gold nanoparticles (AuNPs) have been extensively explored in biomedical applications, for example as drug carriers, contrast agents, or therapeutics. However, AuNP can exhibit cytotoxic profile, when the size is below 2 nm (ultrasmall AuNP; usAuNP) and when the stabilizing ligands allow for access to the gold surface either for the direct interaction with biomolecules or for catalytic activity of the unshielded gold surface. Furthermore, usAuNP exhibits significantly different biodistribution and enhanced circulation times compared to larger AuNP. This review gives an overview about the synthesis and the physico-chemical properties of usAuNP and, thereby, focusses on 1.4 nm sized AuNP, which are derived from the compound Au55(PPh3)12Cl6 and which are the most intensively studied usAuNP in the field. This part is followed by a summary of the toxic properties of usAuNP, which include in vitro cytotoxicity tests on different cell lines, electrophysiological tests following FDA guidelines as well as studies on antibacterial effects. Finally, the biodistribution and pharmacokinetics of ultrasmall AuNP are discussed and compared to the properties of more biocompatible, larger AuNP.

Differential hERG ion channel activity of ultrasmall gold nanoparticles.

Understanding the mechanism of toxicity of nanomaterials remains a challenge with respect to both mechanisms involved and product regulation. Here we show toxicity of ultrasmall gold nanoparticles (AuNPs). Depending on the ligand chemistry, 1.4-nm-diameter AuNPs failed electrophysiology-based safety testing using human embryonic kidney cell line 293 cells expressing human ether-á-go-go-Related gene (hERG), a Food and Drug Administration-established drug safety test. In patch-clamp experiments, phosphine-stabilized AuNPs irreversibly blocked hERG channels, whereas thiol-stabilized AuNPs of similar size had no effect in vitro, and neither particle blocked the channel in vivo. We conclude that safety regulations may need to be reevaluated and adapted to reflect the fact that the binding modality of surface functional groups becomes a relevant parameter for the design of nanoscale bioactive compounds.

Wide Band-Gap Bismuth-based p-Dopants for Opto-Electronic Applications.

Ten new efficient p-dopants for conductivity doping of organic semiconductors for OLEDs are identified. The key advantage of the electrophilic tris(carboxylato) bismuth(III) compounds is the unique low absorption of the resulting doped layers which promotes the efficiency of OLED devices. The combination of these features with their low fabrication cost, volatility, and stability, make these materials very attractive as dopants in organic electronics.

Size dependent translocation and fetal accumulation of gold nanoparticles from maternal blood in the rat.

BACKGROUND: There is evidence that nanoparticles (NP) cross epithelial and endothelial body barriers. We hypothesized that gold (Au) NP, once in the blood circulation of pregnant rats, will cross the placental barrier during pregnancy size-dependently and accumulate in the fetal organism by 1. transcellular transport across the hemochorial placenta, 2. transcellular transport across amniotic membranes 3. transport through ~20 nm wide transtrophoblastic channels in a size dependent manner. The three AuNP sizes used to test this hypothesis are either well below, or of similar size or well above the diameters of the transtrophoblastic channels. METHODS: We intravenously injected monodisperse, negatively charged, radio-labelled 1.4 nm, 18 nm and 80 nm ¹98AuNP at a mass dose of 5, 3 and 27 µg/rat, respectively, into pregnant rats on day 18 of gestation and in non-pregnant control rats and studied the biodistribution in a quantitative manner based on the radio-analysis of the stably labelled ¹98AuNP after 24 hours. RESULTS: We observed significant biokinetic differences between pregnant and non-pregnant rats. AuNP fractions in the uterus of pregnant rats were at least one order of magnitude higher for each particle size roughly proportional to the enlarged size and weight of the pregnant uterus. All three sizes of ¹98AuNP were found in the placentas and amniotic fluids with 1.4 nm AuNP fractions being two orders of magnitude higher than those of the larger AuNP on a mass base. In the fetuses, only fractions of 0.0006 (30 ng) and 0.00004 (0.1 ng) of 1.4 nm and 18 nm AuNP, respectively, were detected, but no 80 nm AuNP (<0.000004 (<0.1 ng)). These data show that no AuNP entered the fetuses from amniotic fluids within 24 hours but indicate that AuNP translocation occurs across the placental tissues either through transtrophoblastic channels and/or via transcellular processes. CONCLUSION: Our data suggest that the translocation of AuNP from maternal blood into the fetus is NP-size dependent which is due to mechanisms involving (1) transport through transtrophoblastic channels - also present in the human placenta - and/or (2) endocytotic and diffusive processes across the placental barrier.

Dibenzoazepine hydrazine is a building block for N-alkene hybrid ligands: exploratory syntheses of complexes of Cu, Fe, and Li.

The new hydrazine 5H-dibenzo[b,f]azepin-5-amine (2) reacts with P- and Si-electrophiles via deprotonation to afford P(III)-, P(V)-, and TMS-hydrazides 3-8 and with carbonyl electrophiles via acid-free condensation to the N-substituted hydrazones 9-12 that are potential N-alkene ligands. While ß-ketohydrazone 9 and α-dihydrazone 10 react with [Mes(Cu)]4, [Cu(NCCCH3)4]2PF6, and FeCl2(THF)1.5 to afford complexes devoid of alkene interaction, [Cu(OTf)]2·C6H6 reacts with the α-keto hydrazone 11 or with N,N dimethyl-hydrazone 12 to form the neutral dimeric Cu(I) complex 18 with bridging Cu(I)-alkene interactions or the tetrahedral cationic complex 19 in which 12 binds as a bidentate hydrazone-alkene ligand, respectively. The surprising stability of the alkene coordination in complexes 18 and 19 prevents substitutions with, e.g., PPh3.

Diarylformamides as a safe reservoir and room temperature source of ultra-pure CO for a 'green' rWGS reaction.

Diarylformamides are shown to be a safe reservoir and source of CO. Perfectly selective decarbonylation is achieved in solution at room temperature with potassium and cesium diarylamide catalysts. Moreover, solvent-free decarbonylations may be run either in a diphenylformamide melt at 70 ºC or, when the bisformamide 9 is used, in the solid state at 88 ºC in virtue of its improved atom economy. These These simple and practical transition-metal-free reactions afford ultra-pure (i.e. dry and solvent-free) CO at moderate temperatures and the byproduct diarylamines are recycled as pure compounds. In the absence of catalysts, diarylformamides 1 and 9 are long-term stable at > 200 ºC.  DFT-calculations indicate a reaction pathway with a rate-determining deprotonation of Ph2NC(O)H and a barrier-free CO elimination from Ph2NC(O)-.

Trapping of soluble, KCl-stabilized Cu(I) hydrides with CO2 gives crystalline formates.

Cu(I)-Hydrido complexes supported by dibenzo[b,f]azepinyl P-alkene hybrid ligands and stabilized by electrostatic interactions in a Cu-H⋯KCl⋯BR3 arrangement can be trapped with CO2 at low temperature to afford Cu(I)-formates. The complexes are isolable with and without a pendant BEt3 group and show strong Cu-O and weak B-O interactions.

Low-voltage organic transistors with an amorphous molecular gate dielectric.

Organic thin film transistors (TFTs) are of interest for a variety of large-area electronic applications, such as displays, sensors and electronic barcodes. One of the key problems with existing organic TFTs is their large operating voltage, which often exceeds 20 V. This is due to poor capacitive coupling through relatively thick gate dielectric layers: these dielectrics are usually either inorganic oxides or nitrides, or insulating polymers, and are often thicker than 100 nm to minimize gate leakage currents. Here we demonstrate a manufacturing process for TFTs with a 2.5-nm-thick molecular self-assembled monolayer (SAM) gate dielectric and a high-mobility organic semiconductor (pentacene). These TFTs operate with supply voltages of less than 2 V, yet have gate currents that are lower than those of advanced silicon field-effect transistors with SiO2 dielectrics. These results should therefore increase the prospects of using organic TFTs in low-power applications (such as portable devices). Moreover, molecular SAMs may even be of interest for advanced silicon transistors where the continued reduction in dielectric thickness leads to ever greater gate leakage and power dissipation.

Gold nanoparticles of diameter 1.4 nm trigger necrosis by oxidative stress and mitochondrial damage.

Gold nanoparticles (AuNPs) are generally considered nontoxic, similar to bulk gold, which is inert and biocompatible. AuNPs of diameter 1.4 nm capped with triphenylphosphine monosulfonate (TPPMS), Au1.4MS, are much more cytotoxic than 15-nm nanoparticles (Au15MS) of similar chemical composition. Here, major cell-death pathways are studied and it is determined that the cytotoxicity is caused by oxidative stress. Indicators of oxidative stress, reactive oxygen species (ROS), mitochondrial potential and integrity, and mitochondrial substrate reduction are all compromised. Genome-wide expression profiling using DNA gene arrays indicates robust upregulation of stress-related genes after 6 and 12 h of incubation with a 2 x IC50 concentration of Au1.4MS but not with Au15MS nanoparticles. The caspase inhibitor Z-VAD-fmk does not rescue the cells, which suggests that necrosis, not apoptosis, is the predominant pathway at this concentration. Pretreatment of the nanoparticles with reducing agents/antioxidants N-acetylcysteine, glutathione, and TPPMS reduces the toxicity of Au1.4MS. AuNPs of similar size but capped with glutathione (Au1.1GSH) likewise do not induce oxidative stress. Besides the size dependency of AuNP toxicity, ligand chemistry is a critical parameter determining the degree of cytotoxicity. AuNP exposure most likely causes oxidative stress that is amplified by mitochondrial damage. Au1.4MS nanoparticle cytotoxicity is associated with oxidative stress, endogenous ROS production, and depletion of the intracellular antioxidant pool.

Size-dependent cytotoxicity of gold nanoparticles.

Gold nanoparticles are widely used in biomedical imaging and diagnostic tests. Based on their established use in the laboratory and the chemical stability of Au(0), gold nanoparticles were expected to be safe. The recent literature, however, contains conflicting data regarding the cytotoxicity of gold nanoparticles. Against this background a systematic study of water-soluble gold nanoparticles stabilized by triphenylphosphine derivatives ranging in size from 0.8 to 15 nm is made. The cytotoxicity of these particles in four cell lines representing major functional cell types with barrier and phagocyte function are tested. Connective tissue fibroblasts, epithelial cells, macrophages, and melanoma cells prove most sensitive to gold particles 1.4 nm in size, which results in IC(50) values ranging from 30 to 56 microM depending on the particular 1.4-nm Au compound-cell line combination. In contrast, gold particles 15 nm in size and Tauredon (gold thiomalate) are nontoxic at up to 60-fold and 100-fold higher concentrations, respectively. The cellular response is size dependent, in that 1.4-nm particles cause predominantly rapid cell death by necrosis within 12 h while closely related particles 1.2 nm in diameter effect predominantly programmed cell death by apoptosis.

Nanostructured silicon surfaces via nanoporous alumina.

Nanostructured silicon surfaces are generated using nanoporous alumina membranes as stamps to imprint PMMA films on silicon, followed by reactive ion etching (RIE).

Mononuclear Molybdenum(IV) Complexes with Two Multiply Bonded Chalcogen Ligands in Trans Configuration and Chelating Biphosphine Ligands.

A series of molybdenum(IV) complexes of the type trans-Mo(Q)(Q')(P&arcraise;P)(2) has been prepared where Q and Q' are chalcogen ligands (O, S, Se, Te) and P&arcraise;P is either cis-1,2-bis(diphenylphosphino)ethylene (dppee) or 1,2-bis(diphenylphosphino)ethane (dppe). X-ray crystallographic studies were carried out to investigate how the Mo-Q distance is influenced by the mutually competitive d(pi)-p(pi) interactions between the p(x)() and p(y)() orbitals of the chalcogen ligands and the d(xz)() and d(yz)() orbitals of the molybdenum center. trans-Mo(O)(2)(dppee)(2) (1) has been prepared by the hydrolysis and deprotonation reaction of [Mo(O)(Cl)(dppee)(2)]Cl with NaOH in methanol. The compounds where Q represents the heavier chalcogens (S, Se, Te) have been prepared by the reaction between trans-Mo(N(2))(2)(P&arcraise;P)(2) and a chalcogen source: trans-Mo(S)(2)(dppee)(2) (2), BzS(3)Bz (dibenzyl trisulfide); trans-Mo(Se)(2)(dppee)(2) (3), elemental Se; trans-Mo(Te)(2)(dppee)(2) (4), TePEt(3) (Et = ethyl); trans-Mo(S)(2)(dppe)(2) (5), BzS(3)Bz; trans-Mo(Se)(2)(dppe)(2) (6), Se. trans-Mo(O)(S)(dppee)(2) (7) was obtained from the reaction of MoCl(3)(THF)(3) (THF = tetrahydrofuran), dppee, and NaHS in a mixture of THF and methanol. The attempted preparation of 7 by the reaction of SO(2) and trans-Mo(N(2))(2)(dppee)(2) yielded Mo(SO(2))(2)(dppee)(2) (8). 1 crystallizes in the monoclinic space group P2(1)/c (No. 14, Z = 2) with a = 11.1340(15) Å, b = 18.435(2) Å, c = 12.515(2) Å, and beta = 110.999(9) degrees; 2 crystallizes in the triclinic space group P&onemacr; (No. 2, Z = 1) with a = 10.102(4) Å, b = 10.722(4) Å, c = 12.195(3) Å, alpha = 100.95(3) degrees, beta = 95.04(4) degrees, and gamma = 117.81(2) degrees; 3 crystallizes in the monoclinic space group P2(1)/c (No. 14, Z = 2) with a = 11.186(5) Å, b = 18.005(8) Å, c = 12.761(9) Å, and beta = 110.35(4) degrees; 4 crystallizes in the triclinic space group P&onemacr; (No. 2, Z = 2) with a = 12.681(4) Å, b = 19.280(5) Å, c = 10.454(3) Å, alpha = 104.60(2) degrees, beta = 111.61(2) degrees, and gamma = 75.12(2) degrees; 5 crystallizes in the monoclinic space group C2/c (No. 15, Z = 8) with a = 49.515(7) Å, b = 10.9286(12) Å, c = 18.203(3) Å, and beta = 98.306(12) degrees; 6 crystallizes in the monoclinic space group C2/c (No. 15, Z = 8) with a = 49.566(9) Å, b = 10.9765(15) Å, c = 18.282(3) Å, and beta = 98.541(13) degrees; 7 crystallizes in the triclinic space group P&onemacr; (No. 2, Z = 1) with a = 10.040(1) Å, b = 10.563(1) Å, c = 12.162(2) Å, alpha = 75.30(1) degrees, beta = 85.93(1) degrees, and gamma = 63.21(1) degrees; 8 crystallizes in the monoclinic space group C2/c (No. 15, Z = 4) with a = 21.534(6) Å, b = 12.4271(13) Å, c = 19.550(5) Å, and beta = 118.480(14) degrees. The UV/vis and the (31)P{(1)H} NMR data for compounds 1-7 are also reported and discussed.

The First Structure Determination of Nanosized Colloidal Particles of Pd3 P by High-Resolution Electron Microscopy.

The exact three-dimensional structure of a nanosized colloidal particle of Pd3 P was determined directly from high-resolution transmission electron microscopy (HRTEM) images that were recorded in several crystallographic directions. An HRTEM image recorded along [011] is shown on the right. The cores of the particles were excluded from the analysis because of severe multiple diffraction.

Fluorinated copper(I) carboxylates as advanced tunable p-dopants for organic light-emitting diodes.

Volatile copper(I) benzoates with variable degrees of fluorination are used for p-doping of organic hole-transport layers in single-carrier devices, charge-generation layers, and in organic light-emitting diodes. The charge-transport abilities of the doped materials correlate with the degree and position of the fluorination on the aromatic ring of the carboxylate groups.

Air-blood barrier translocation of tracheally instilled gold nanoparticles inversely depends on particle size.

Gold nanoparticles (AuNP) provide many opportunities in imaging, diagnostics, and therapy in nanomedicine. For the assessment of AuNP biokinetics, we intratracheally instilled into rats a suite of (198)Au-radio-labeled monodisperse, well-characterized, negatively charged AuNP of five different sizes (1.4, 2.8, 5, 18, 80, 200 nm) and 2.8 nm AuNP with positive surface charges. At 1, 3, and 24 h, the biodistribution of the AuNP was quantitatively measured by gamma-spectrometry to be used for comprehensive risk assessment. Our study shows that as AuNP get smaller, they are more likely to cross the air-blood barrier (ABB) depending strongly on the inverse diameter d(-1) of their gold core, i.e., their specific surface area (SSA). So, 1.4 nm AuNP (highest SSA) translocated most, while 80 nm AuNP (lowest SSA) translocated least, but 200 nm particles did not follow the d(-1) relation translocating significantly higher than 80 nm AuNP. However, relative to the AuNP that had crossed the ABB, their retention in most of the secondary organs and tissues was SSA-independent. Only renal filtration, retention in blood, and excretion via urine further declined with d(-1) of AuNP core. Translocation of 5, 18, and 80 nm AuNP is virtually complete after 1 h, while 1.4 nm AuNP continue to translocate until 3 h. Translocation of negatively charged 2.8 nm AuNP was significantly higher than for positively charged 2.8 nm AuNP. Our study shows that translocation across the ABB and accumulation and retention in secondary organs and tissues are two distinct processes, both depending specifically on particle characteristics such as SSA and surface charge.

Size and surface charge of gold nanoparticles determine absorption across intestinal barriers and accumulation in secondary target organs after oral administration.

It is of urgent need to identify the exact physico-chemical characteristics which allow maximum uptake and accumulation in secondary target organs of nanoparticulate drug delivery systems after oral ingestion. We administered radiolabelled gold nanoparticles in different sizes (1.4-200 nm) with negative surface charge and 2.8 nm nanoparticles with opposite surface charges by intra-oesophageal instillation into healthy adult female rats. The quantitative amount of the particles in organs, tissues and excrements was measured after 24 h by gamma-spectroscopy. The highest accumulation in secondary organs was mostly found for 1.4 nm particles; the negatively charged particles were accumulated mostly more than positively charged particles. Importantly, 18 nm particles show a higher accumulation in brain and heart compared to other sized particles. No general rule accumulation can be made so far. Therefore, specialized drug delivery systems via the oral route have to be individually designed, depending on the respective target organ.

Particle size-dependent and surface charge-dependent biodistribution of gold nanoparticles after intravenous administration.

Gold nanoparticles (GNP) provide many opportunities in imaging, diagnostics, and therapies of nanomedicine. Hence, their biokinetics in the body are prerequisites for specific tailoring of nanomedicinal applications and for a comprehensive risk assessment. We administered (198)Au-radio-labelled monodisperse, negatively charged GNP of five different sizes (1.4, 5, 18, 80, and 200 nm) and 2.8 nm GNP with opposite surface charges by intravenous injection into rats. After 24h, the biodistribution of the GNP was quantitatively measured by gamma-spectrometry. The size and surface charge of GNP strongly determine the biodistribution. Most GNP accumulated in the liver increased from 50% of 1.4 nm GNP to >99% of 200 nm GNP. In contrast, there was little size-dependent accumulation of 18-200 nm GNP in most other organs. However, for GNP between 1.4 nm and 5 nm, the accumulation increased sharply with decreasing size; i.e. a linear increase with the volumetric specific surface area. The differently charged 2.8 nm GNP led to significantly different accumulations in several organs. We conclude that the alterations of accumulation in the various organs and tissues, depending on GNP size and surface charge, are mediated by dynamic protein binding and exchange. A better understanding of these mechanisms will improve drug delivery and dose estimates used in risk assessment.